What to Watch: TRXS
The Canary Staked TRX ETF (NASDAQ:TRXS) is one of the newest entries in the wave of altcoin spot ETFs that followed Bitcoin and Ether approvals, and it sits in a category that barely existed…
ETF
Exchange Traded Funds
All ETF Articles
Newest first · Page 13
North American Gold ETF Buying Jumped From $71 Million to $7.7 Billion in One Month. Can GLDM Hold Up?
Gold ETF inflows across North America surged to levels that shocked even veteran commodity watchers, but a simultaneous spike in real yields now puts the entire trade on trial. Whether August's buying spree becomes…
The HBM Pricing Cycle That Will Define SKHQ in 2026
SK Hynix just posted one of the most explosive quarters in memory chip history, which makes the inverse ETF designed to profit from its collapse either the smartest hedge on the shelf or the…
PJSM Investors: Watch This One Macro Signal Over the Next 12 Months
PGIM's newly launched small-mid cap active ETF carries a compelling premise from Jennison Associates, but a Treasury market sitting at a 12-month extreme threatens to swamp whatever stock-picking edge the manager brings.
If Memory Chip Prices Fall, Here’s What Happens to the Korea Semiconductor ETF KCHP
Korea's newest chip ETF bets almost everything on two memory giants at the exact moment HBM pricing and AI capex commitments could swing either way, and the fund is young enough that most investors…
HQDG Dividend Growth ETF Launches Into Rising Rates: Here’s What Matters Most
A brand-new dividend-growth ETF just launched into the worst possible rate environment, and the one macro number sitting at a 12-month extreme will decide whether it thrives or stalls before most investors even notice…
DIVH’s First Portfolio Disclosure Could Reshape Your Dividend Strategy
A brand-new dividend ETF just launched into what may be the worst possible macro environment for its strategy, and the one signal investors need to watch has nothing to do with the fund itself.
U.S. Export Controls on Chinese Memory Chips Could Make or Break CRAM in 2026
A brand-new ETF targeting China's memory chip supply chain just posted a 4% gain on one of its first trading days, but with no published holdings and a regulatory environment that can reprice the…
AIMG’s Biggest Test Comes When Cloud Giants Report December Results
Defiance's newest AI ETF bets everything on roughly ten names, which means a single bad earnings call could rattle the entire fund. Before you buy, there are two specific signals worth tracking that most…
If Long-Duration Rates Stay Above 5%, Here’s What AIFR Investors Should Expect
Defiance's new foundry ETF trades at a moment when long-duration rates and Taiwan Strait tensions could either turbocharge or torpedo the entire thematic bet, and the first few weeks of price discovery will reveal…
What ACBE Investors Need to Watch Before Volatility Reshapes Their Coupons
A brand-new ETF is pitching enhanced coupon income from autocallable structured notes at exactly the moment risk-free yields are making that case hardest to win. What two signals will reveal whether ACBE can actually…
SPHD and SCHD Both Promise High Dividends, Yet One Has Barely Made Investors Any Money in a Decade
SPHD and SCHD both court dividend investors with promises of reliable income from established U.S. companies, yet a decade of returns reveals a stunning divide hiding beneath their nearly identical pitches.
Forget IDV: Vanguard’s VYMI Returned 29% in a Year While Charging Just 0.07%
IDV has delivered income investors a reliable yield for years, but a rival international dividend ETF with a fraction of the fees quietly outpaced it over the last 12 months, and the gap raises…
Your Winners Pushed You to 80% Stocks at 68. Sell Them Now or Let Them Ride? These 4 ETFs Make the Trim Painless
A decade of gains left your portfolio at 80% stocks at age 68, and simply cashing out your winners could trigger a tax bill you never saw coming. Four ETFs offer a smarter path…
We Checked 14 Dividend ETFs Against SCHD in 2026. Not One Beat It
We put 14 dividend ETFs through a head-to-head test against SCHD in 2026, covering total return, dividend growth, and portfolio quality, and every single one came up short. The reasons why reveal something important…